AlphaQuest LLC Sells 27,100 Shares of Alignment Healthcare, Inc. $ALHC

AlphaQuest LLC decreased its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 92.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,240 shares of the company’s stock after selling 27,100 shares during the quarter. AlphaQuest LLC’s holdings in Alignment Healthcare were worth $39,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ALHC. Royal Bank of Canada increased its holdings in shares of Alignment Healthcare by 92.6% during the first quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock worth $1,720,000 after purchasing an additional 44,413 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Alignment Healthcare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after buying an additional 2,594 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Alignment Healthcare by 79.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after acquiring an additional 429,703 shares during the period. Woodline Partners LP bought a new position in Alignment Healthcare during the 1st quarter worth $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Alignment Healthcare by 16.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after acquiring an additional 44,452 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analysts Set New Price Targets

ALHC has been the topic of several analyst reports. JPMorgan Chase & Co. increased their target price on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a report on Friday, January 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Finally, Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $23.32.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 180,000 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $20.49, for a total transaction of $3,688,200.00. Following the sale, the chief executive officer owned 2,652,641 shares of the company’s stock, valued at approximately $54,352,614.09. The trade was a 6.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Hyong Kim sold 16,506 shares of the company’s stock in a transaction on Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total transaction of $352,403.10. Following the transaction, the insider owned 333,133 shares of the company’s stock, valued at $7,112,389.55. This trade represents a 4.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,120,938 shares of company stock worth $41,655,670 in the last ninety days. Insiders own 6.60% of the company’s stock.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $20.19 on Monday. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market cap of $4.04 billion, a PE ratio of -168.25, a P/E/G ratio of 5.14 and a beta of 1.16. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87. The business’s 50-day moving average price is $20.90 and its two-hundred day moving average price is $18.13.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.